Dexcom has introduced Stelo. An over-the-counter glucose biosensor built specifically for Type 2 diabetics not on insulin. It removes the one big obstacle from wearing a CGM. You don’t need a prescription to get one.
That’s the thing about denial. It doesn’t just show up at the dinner table. It shows up in the decision not to call the doctor, not to ask for a CGM prescription, not to deal with the insurance fight and co-pays. Stelo takes all of that off the table. You order it, you put it on, and the truth starts arriving every five minutes whether you were ready for it or not.
Stelo is a 15-day continuous glucose biosensor made by Dexcom, the same company behind the G7, built on the same core sensor technology. A small sensor attaches to the back of your upper arm. A filament thinner than a human hair sits just beneath the skin and reads your interstitial glucose around the clock, sending readings to the Stelo app on your phone every five minutes.
No calibration. No finger sticks. No prescription. You order it at stelo.com or pick it up at a pharmacy, apply it yourself in about a minute, and you’re connected to your own glucose data for the next 15 days. When the sensor expires, you swap it.
Where Stelo differs from the G7 is in who it’s designed for. Stelo is built specifically for adults with Type 2 diabetes who are not on insulin, and for anyone who wants to understand their glucose without entering the clinical prescription system. That includes a lot of Denyabetics™ who never started because the prescription step felt like too much to deal with.
Stelo is FDA-cleared as an over-the-counter device. You can buy it at stelo.com the same way you’d buy a glucose meter at a pharmacy, except it is dramatically more useful than a glucose meter. No gate. No delay. No excuse not to know.
This is the part that matters most. The G7 requires a prescription, a doctor’s visit, a conversation you may have been avoiding, insurance navigation, and a waiting period. For a Denyabetic™, every one of those steps is an exit ramp. Stelo eliminates them.
It’s also FSA and HSA eligible, which means if you have a flexible spending or health savings account, this is exactly what those funds exist for.
I set my personal target range at 70–185 mg/dL. The area below 185 which my doctor called the Goldilocks Zone. Readings above that ceiling is when things start going sideways. Not dangerously, not immediately, but consistently. Glucose above that level for sustained periods drives inflammation, accelerates glycation, and over time adds up to the damage that makes diabetes progressive. Before I wore a CGM, I had no idea how often I was crossing that line.
Stelo shows you which foods spike you, which habits protect you, and which rationalizations are quietly costing you. The difference is that Stelo gets you there without requiring you to navigate the healthcare system first.
Stelo gives you behavioral data, a continuous record of how your specific body responds to your specific food choices, activity level, stress, and sleep. That data is genuinely different for every person. The same meal that sends one person to 195 might only move another to 145. Stelo stops you from guessing.
The Stelo app also includes built-in AI coaching, personalized tips based on your actual glucose patterns rather than generic advice. Morning recaps, trend analysis, and insight flags tell you what’s worth paying attention to. For a Type 2 diabetic who doesn’t have a diabetes care team on speed dial, this kind of real-time, personalized feedback is genuinely different from anything that existed before.
“When a Denyabetic™ can see the truth using technology without a prescription…that’s a huge win”
Stelo is $99 for a two-sensor pack, a 30-day supply. Available directly at stelo.com and FSA/HSA eligible. No insurance required, no prior authorization, no waiting on a specialty pharmacy. If you have been sitting on a health savings account balance, this is one of the clearest legitimate uses for it.
I started with the Dexcom G7 and it is an exceptional device. If you are on insulin, or if you have coverage that makes the G7 accessible without a fight, it remains the clinical gold standard. The G7 has predictive low alerts, integrates with insulin pumps, and is appropriate for more complex diabetes management.
But if you are a Type 2 diabetic not on insulin and you have been putting off starting a CGM because of the prescription requirement, the insurance process, or simply the inertia of dealing with any of it, Stelo is the answer. Same company. Same core technology. Zero prescription required.
Stelo™ and Dexcom® are trademarks of Dexcom, Inc. This page reflects personal experience and research only and is not sponsored by or affiliated with Dexcom, Inc. in any way. This is not medical advice.
References
Please understand that I’m not a doctor, and everything on this site reflects my own research and personal experience managing Type 2 diabetes. It is provided for informational and educational purposes only — not as medical advice, diagnosis, or treatment.
Before starting any supplement, changing your diet, or adjusting your medications, consult your physician or a qualified healthcare provider. Individual results vary. Never delay or disregard professional medical advice because of something you read here.
Product photos and brand names appear for illustrative purposes only. Denyabetic does not endorse, sponsor, or have any commercial relationship with any brand shown unless explicitly stated.
These statements have not been evaluated by the Food and Drug Administration. No product or protocol discussed on this site is intended to diagnose, treat, cure, or prevent any disease.